In a landmark case, Gordon G. May, in collaboration with his partner David C. Grant, successfully defended a corporation and its CEO against allegations of making a fraudulent claim on the corporation’s Directors and Officers insurance policy. The lawsuit, brought by the plaintiff, sought damages exceeding $100 million and involved accusations of theft of trade secrets related to the development of the first microchips used for DNA analysis.
The case was exceptionally complex, requiring a detailed understanding of both trade secret law and the intricacies of corporate insurance policies. Over the course of a three-month bench trial, the GGB Litigation team meticulously presented evidence and crafted compelling arguments to dismantle the plaintiff’s claims. Gordon and David’s strategic collaboration and thorough preparation were instrumental in navigating the numerous challenges presented by the case.
Following the trial, extensive post-trial briefing further reinforced our defense. The court’s findings of fact decisively favored our clients, concluding that the corporation and its CEO had no intent to defraud and were not liable for the allegations made against them.
